Average Co-Inventor Count = 3.36
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nikang Therapeutics, Inc. (14 from 15 patents)
14 patents:
1. 12435034 - Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
2. 12415779 - Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
3. 12391642 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
4. 12264167 - Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
5. 12171741 - 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
6. 12077506 - Indane derivatives as hypoxia inducible factor-2(α) inhibitors
7. 11753366 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
8. 11634382 - Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
9. 11518772 - Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
10. 11459340 - Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
11. 11420936 - Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
12. 11267782 - Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
13. 11034705 - Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
14. 10894797 - Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors